Aurinia: Q2 Earnings Snapshot
By AP News
Published - Aug 01, 2024, 10:03 AM ET
Last Updated - Aug 01, 2024, 10:03 AM EDT
EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported second-quarter net income of $722,000, after reporting a loss in the same period a year earlier.
The Edmonton, Alberta-based company said it had profit of 1 cent per share. Earnings, adjusted for restructuring costs, were 2 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share.
The biotechnology company posted revenue of $57.2 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $54.9 million.
